InvestorsHub Logo
Post# of 252279
Next 10
Followers 834
Posts 119885
Boards Moderated 17
Alias Born 09/05/2002

Re: None

Friday, 07/10/2020 10:35:17 AM

Friday, July 10, 2020 10:35:17 AM

Post# of 252279
NKTX IPOs 16.1M* shares @$18.00:

https://www.globenewswire.com/news-release/2020/07/10/2060366/0/en/Nkarta-Announces-Pricing-of-Initial-Public-Offering.html

Nkarta, Inc. focuses on combining its natural killer (NK) cell expansion and cryopreservation platform with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of tumor targets, and improve persistence for sustained activity in the body for the treatment of cancer. Nkarta’s mission is to discover, develop and deliver novel off-the-shelf NK cell therapy product candidates that have a profound impact on patients.

*Assuming exercise of underwriter’s option.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.